ABCL vs. SGMO
Compare and contrast key facts about AbCellera Biologics Inc. (ABCL) and Sangamo Therapeutics, Inc. (SGMO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABCL or SGMO.
Correlation
The correlation between ABCL and SGMO is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ABCL vs. SGMO - Performance Comparison
Key characteristics
ABCL:
-0.55
SGMO:
1.04
ABCL:
-0.57
SGMO:
2.44
ABCL:
0.94
SGMO:
1.32
ABCL:
-0.34
SGMO:
1.73
ABCL:
-0.79
SGMO:
3.80
ABCL:
41.27%
SGMO:
45.26%
ABCL:
58.81%
SGMO:
165.22%
ABCL:
-95.94%
SGMO:
-99.40%
ABCL:
-94.01%
SGMO:
-97.72%
Fundamentals
ABCL:
$903.82M
SGMO:
$563.24M
ABCL:
-$0.61
SGMO:
-$1.24
ABCL:
$23.78M
SGMO:
$50.25M
ABCL:
-$59.31M
SGMO:
$45.15M
ABCL:
-$156.94M
SGMO:
-$67.72M
Returns By Period
In the year-to-date period, ABCL achieves a 20.48% return, which is significantly higher than SGMO's 10.78% return.
ABCL
20.48%
20.89%
17.28%
-33.52%
N/A
N/A
SGMO
10.78%
-54.25%
181.58%
148.52%
-32.51%
-21.97%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABCL vs. SGMO — Risk-Adjusted Performance Rank
ABCL
SGMO
ABCL vs. SGMO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and Sangamo Therapeutics, Inc. (SGMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABCL vs. SGMO - Dividend Comparison
Neither ABCL nor SGMO has paid dividends to shareholders.
Drawdowns
ABCL vs. SGMO - Drawdown Comparison
The maximum ABCL drawdown since its inception was -95.94%, roughly equal to the maximum SGMO drawdown of -99.40%. Use the drawdown chart below to compare losses from any high point for ABCL and SGMO. For additional features, visit the drawdowns tool.
Volatility
ABCL vs. SGMO - Volatility Comparison
The current volatility for AbCellera Biologics Inc. (ABCL) is 23.26%, while Sangamo Therapeutics, Inc. (SGMO) has a volatility of 88.50%. This indicates that ABCL experiences smaller price fluctuations and is considered to be less risky than SGMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ABCL vs. SGMO - Financials Comparison
This section allows you to compare key financial metrics between AbCellera Biologics Inc. and Sangamo Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities